| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0002 | 1 |